Aldo Miccio

Chairman

Aldo has enjoyed an extensive international career in senior management and governance. His broad experience, spanning 27 years, includes executive chairmanships and directorships for entities across Asia Pacific in industries ranging from property, retail, agriculture and FMCG to public and state services. With an entrepreneurial spirit and strong commercial background, his expertise includes strategic planning, product management, product design and sales and marketing.

In the late 1990s, he started Bissi Ltd, a successful apparel company which, at its peak, grew to over A$15 million in annual sales. This afforded the opportunity to develop strong ties to production offices in China and over the last seven years he has further developed a particular focus on growing business networks and fostering export relations between New Zealand and China.

He sold Bissi Ltd in 2010, by which time he had established himself as first a Councillor, and then Mayor of Nelson City serving a total of six years in public office. Under his leadership, Nelson achieved economic success and regional growth. He was instrumental in successfully negotiating and championing the bid to win the rights to host three Rugby World Cup 2011 games and three Cricket World Cup 2015 matches in Nelson.

He also brought a number of sporting events and food and arts festival events to Nelson during his four years as Director of Trafalgar Events. Aldo has held a number of not-for-profit trustee and governance roles in healthcare, science, the arts and sports, working to enhance the community wellbeing and enable changes in people’s lives and health outcomes. This was also a key driver in Aldo co-founding Medical Kiwi Ltd in 2018.

In addition to Medical Kiwi Ltd, Aldo is currently managing and directing exciting fast growing businesses including New Zealand Coastal Seafoods and KELA Charms. He is Vice President of the Italian Chamber of Commerce in New Zealand. Aldo has a Bachelor of Commerce in Business Administration, Management Science and Operations.

Peter Win

Director (Operations and Management)

Peter has considerable breadth and depth of business experience, with a passion for pioneering new industries. His vast experience has afforded him a broad knowledge base about what it takes to make a company work effectively and successfully. Peter has worked in some of the most technically advanced industries, reaching senior levels of management in large-scale energy projects in Norway, Nigeria and China and the marine engineering industry in New Zealand.

With a drive to get projects moving forward, Peter has been instrumental in the start-up and growth of several businesses. He founded and managed Elanz Ltd, a niche food and beverage business that exported locally produced premium products to international markets including China and Southeast Asia. He identified an opportunity to process and distribute Ling maw into Asia and in 2016, with an interest in developing value-added products, he co-founded and is CEO of New Zealand Coastal Seafoods that is currently undergoing a process that will see it listed on the ASX.

For a number of years, Peter had been monitoring what was happening internationally in the medicinal cannabis industry. The recent law changes in New Zealand provided the opportunity to make a medicinal cannabis business commercial and in 2018, Peter co-founded Medical Kiwi Ltd. His motivation is a strong belief regarding the social wellbeing and health benefits for the wider community, after personally experiencing how the industry has helped build better communities overseas.

Dr David Porter, MBChB, FRACP

Director (Medical)

David is a Consultant Rheumatologist with a busy rheumatology practice in Nelson. Porter Rheumatology provides specialist medical and nursing care to people with auto-immune and inflammatory disorders, as well as fibromyalgia patients. David is committed to finding more effective, accessible and affordable ways to manage his patient’s pain.

Porter Rheumatology is actively involved in clinical trial research investigating new rheumatology drugs, having taken part in 15 clinical trials to date. For the past 12 months, David has been prescribing cannabidiol for his fibromyalgia patients and has seen significant benefits, particularly the lack of side effects, improved sleep, calmness, mental alertness and pain management. David joined Medical Kiwi as a Director because he is passionate about providing the highest quality medicinal cannabis products with the considerable benefits they bring to patients at the best possible price point.

David has 27 years’ experience in the medical field, including 15 years as a General Medicine Specialist including work in general medicine, intensive care, cardiology, gastroenterology, neurology and general and vascular surgery.

He has undertaken extensive general medicine and rheumatology training in New Zealand, the United Kingdom, and, as the 2003 Rose Hellaby Scholar, Australia. He is a fellow of the Royal Australian College of Physicians and a member of the New Zealand Rheumatology Association, American College of Rheumatology, and American College of Physicians.

Dr Michael Packer, PhD (Biochemistry, Cell Biology), MSc (Marine Science), BSc (Biochemistry)

Director (Science and Research)

Michael is a biochemist and natural products biotechnologist with a long and extensive track record of scientific research. With a career spanning 28 years in New Zealand and the United States of America, Michael is interested in reducing environmental impact and the optimal use of resources, in particular utilising algae, to achieve this. How to farm algae for carbon recycling/capture, biofuel production, bio-based materials and for healthy food ingredients, bioactives, nutraceuticals and cosmetic ingredients has formed the basis of his research and professional speciality.

As a Senior Research Scientist, he manages algae growing facilities and has established commercial algal farms for the biotechnology industry. His work involves using custom-built bespoke photobioreactors which enables algal growth under controlled conditions. Previous research was commercialised in the US and reached stage three clinical trials. His work has been extensively published in scientific literature.

Michael is a founding member of the Australia, New Zealand Marine Biotechnology Society and has held the position of Vice President for the Society since 2017. He has been involved with the planning of numerous science conventions and forums, an editor for scientific publications and he sits on the Ministry of Business, Innovation and Employments College of Reviewers. Michael joined Medical Kiwi Ltd as a Director to help guide rigorous evidence-based development of natural products for benefiting human health.

Bruce Whall CA, B.Comm (UNSW), FAICD

Chief Financial Officer

Bruce is an experienced senior finance and business executive with wide ranging management experience and a clear understanding of the mechanics of business. With a career spanning 40 years, Bruce has extensive competency across strategic and business planning, mergers and acquisitions, finance, accounting, taxation, working capital management, treasury and operations. He has held senior financial and operational roles in both professional accounting and commerce for private and public large-to-medium commercial businesses, multi-nationals in the United States of America and Japan and small-to-medium businesses in Australia.

Bruce has a Bachelor of Commerce from the University of New South Wales, is a qualified Chartered Accountant and a Fellow of the Australian Institute of Company Directors.

Scroll Up